TABLE 2.
Distribution and ratios of some variables
| n | %* | |
|---|---|---|
| Tumor diameter (cm) | ||
| 2.01–5 | 1 | 7.1 |
| 5.01–9.99 | 3 | 21.4 |
| ≥10 | 10 | 71.4 |
| ≤5 | 1 | 7.1 |
| >5 | 13 | 92.9 |
| <10 | 4 | 28.6 |
| >10 | 10 | 71.4 |
| Mitotic index (/50 HPF) | ||
| ≤5 | 7 | 50.0 |
| 5.01–9.99 | 3 | 21.4 |
| ≥10 | 4 | 28.6 |
| ≤5 | 7 | 50.0 |
| >5 | 7 | 50.0 |
| <10 | 10 | 71.4 |
| >10 | 4 | 28.6 |
| Markers | ||
| CD34 | 11 | 78.6 |
| CD117 | 14 | 100 |
| Desmin | 0 | 0 |
| DOG1 | 5 | 100** |
| S100 | 0 | 0 |
| Necrosis | 8 | 57.1 |
| Rupture | 1 | 7.1 |
| NIH risk category | ||
| Intermediate | 2 | 14.3 |
| High | 12 | 85.7 |
| Operation type | ||
| Mass excision | 4 | 28.6 |
| Whipple + right colon resection | 2 | 14.3 |
| Anterior resection | 1 | 7.1 |
| Mass excision + right hemicolectomy | 1 | 7.1 |
| Mass excision + segmental small bowel resection | 1 | 7.1 |
| Mass excision + distal pancreatectomy + splenectomy | 1 | 7.1 |
| Mass excision + segmental colon resection | 1 | 7.1 |
| Mass excision + TAH BSO | 1 | 7.1 |
| Omentectomy | 1 | 7.1 |
| Segmental small intestine resection + partial bladder resection | 1 | 7.1 |
| Mortality (within the post-op 30 days) | 1 | 7.1 |
| Morbidity | 4 | 28.6 |
| Mortality (during follow-up) | 4 | 28.6 |
| 5-year overall survival | 8 | 80.0 |
| 5-year disease-free survival | 8 | 88.9 |
| Adjuvant treatment (Imatinib) | 11 | 78.6 |
| Recurrence-Metastasis (during follow-up) | 3 | 21.4 |
| Liver | 2 | 14.3 |
| Periton | 1 | 7.1 |
| Synchronous GIST | 0 | 0 |
| Complete resection (R0) | 9 | 64.3 |
*
Some of the total percentages may exceed (or may not reach) 100% due to the low number of the patients and rounding;
**
Among the tested patients; CT: Computed tomography; MRI: Magnetic resonance imaging; TAH BSO: Total abdominal hysterectomy + bilateral salpingooferectomy; GIST: Gastrointestinal stromal tumor.